S. Silventepoirot et al., ROLE OF THE EXTRACELLULAR DOMAINS OF THE CHOLECYSTOKININ RECEPTOR IN AGONIST BINDING, Molecular pharmacology, 54(2), 1998, pp. 364-371
The cholecystokinin (CCK) receptor types A and B (CCKAR and CCKBR) are
G protein-coupled receptors with approximately 50% amino acid identit
y; both have high affinity for the sulfated CCK octapeptide (CCK-8), w
hereas only the CCKBR has high affinity for gastrin. Previously, we id
entified five amino acids in the second extracellular loop (ECL) of th
e CCKBR that were essential for gastrin selectivity. Subsequent mutage
nesis of one of these five amino acids (H207F) resulted in the loss of
radiolabeled CCK-8 binding. CCK-8 stimulated total inositol phosphate
accumulation in COS-1 cells transiently expressing the CCKBR-H207F wi
th full efficacy and a 3044-fold reduced potency, which suggests that
the loss of radioligand binding was caused by a loss in affinity. Alan
ine scanning mutagenesis was performed on the amino terminus near the
top of transmembrane domain I (TM) and on ECL1, two extracellular doma
ins implicated in ligand binding by previous mutagenesis studies. (125
)-Bolton-Hunter-CCK-8 binding to mutant receptors transiently expresse
d in COS-1 identified one nonconserved amino acid, R57A, at the top of
TMI that caused a 21-fold reduction in CCK-8 affinity and four conser
ved amino acids, N115A, L116A, F120A and F122A, in the ECL1 that cause
d a 15.6-, 6-, 440-, and 8-fold reduction in affinity or efficacy. Ala
nine substitution of the equivalent amino acids in the CCKAR correspon
ding to each of the five amino acids in ECL1 and ECL2 affecting CCK-8
affinity for the CCKBR revealed only two mutations, L103A and F107A, t
hat decreased CCK-8 affinity (68- and 2885-fold, respectively). These
data suggest that CCK-8 interacts at multiple contact points in the ex
tracellular domains of CCK receptors and that the CCKAR and CCKBR have
distinct binding sites despite their shared high affinity for CCK-8.